Prolactin-induced expression of vascular endothelial growth factor via Egr-1
Authors:
- Barbara K. VonderhaarBVBarbara K. Vonderhaar
- Josephine F. TrottJTJosephine F. Trott
- Russell C. HoveyRHRussell C. Hovey
- 1 March 2005
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 232 (1-2) , 9-19
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Transcription factor early growth response 1 activity up‐regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblastsArthritis & Rheumatism, 2003
- Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene, 2002
- Antisense Egr‐1 RNA driven by the CMV promoter is an inhibitor of vascular smooth muscle cell proliferation and regrowth after injuryJournal of Cellular Biochemistry, 2002
- The Transcriptional Corepressor NAB2 Blocks Egr-1-Mediated Growth Factor Activation and AngiogenesisBiochemical and Biophysical Research Communications, 2001
- The Antiangiogenic Factor 16K PRL Induces Programmed Cell Death in Endothelial Cells by Caspase ActivationMolecular Endocrinology, 2000
- Proteolysis of Human Prolactin: Resistance to Cathepsin D and Formation of a Nonangiostatic, C-Terminal 16K Fragment by ThrombinEndocrinology, 1999
- 16K Human Prolactin Inhibits Vascular Endothelial Growth Factor-Induced Activation of Ras in Capillary Endothelial CellsMolecular Endocrinology, 1999
- Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.Journal of Clinical Investigation, 1998
- A Regulatory Element in the Human Interleukin 2 Gene Promoter Is a Binding Site for the Zinc Finger Proteins Sp1 and EGR-1Journal of Biological Chemistry, 1995
- Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian CarcinomaJNCI: Journal of the National Cancer Institute, 1995